0000950123-23-001109.txt : 20230208 0000950123-23-001109.hdr.sgml : 20230208 20230208161506 ACCESSION NUMBER: 0000950123-23-001109 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230208 DATE AS OF CHANGE: 20230208 EFFECTIVENESS DATE: 20230208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC CENTRAL INDEX KEY: 0001831423 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20380 FILM NUMBER: 23599262 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6176489100 MAIL ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001831423 XXXXXXXX 12-31-2022 12-31-2022 false Vida Ventures Advisors, LLC
40 Broad Street Suite 201 Boston MA 02109
13F HOLDINGS REPORT 028-20380 N
Jean-Philippe Kouakou-Zebouah Chief Financial Officer 857-254-9492 /s/ Jean-Philippe Kouakou-Zebouah Boston MA 02-08-2023 0 7 74416914 false
INFORMATION TABLE 2 20413.xml INFORMATION TABLE FOR FORM 13F Allogene Therapeutics, Inc. Common Stock 019770106 11310445 1798163 SH SOLE 1798163 0 0 Centessa Pharmaceuticals plc Ordinary Shares 152309100 12188636 3931818 SH SOLE 3931818 0 0 Dyne Therapeutics, Inc. Common Stock 26818M108 25730194 2220034 SH SOLE 2220034 0 0 Kinnate Biopharma, Inc. Common Stock 49705R105 13467409 2207772 SH SOLE 2207772 0 0 Kronos Bio, Inc. Common Stock 50107A104 4479809 2765314 SH SOLE 2765314 0 0 LianBio Ordinary Shares 53000N108 3742618 2282084 SH SOLE 2282084 0 0 Praxis Precision Medicines, Inc. Common Stock 74006W108 3497803 1469665 SH SOLE 1469665 0 0